IDENTITY
CompoundExemestane
BrandBritish Dragon
Strength25 mg/tablet
FormOral Tablet
ClassAromatase Inhibitor (AI)
PHARMACOLOGY
Mechanism Steroidal Aromatase Inactivation
AdministrationOral (PO)
Half-lifeApprox. 24 hours
Estrogen ControlStrong Suppression
ActivityIrreversible Aromatase Binding
SAFETY
Liver StressLow to Moderate
Estrogen ReductionHigh
Lipid ImpactPossible Changes
Joint EffectsPossible Dryness
MonitoringHormone & Lipid Profile
STORAGE & PACKAGE
BrandBritish Dragon
Package100 Tablets
StorageBelow 25°C
ProtectionDry Place Away From Light
FormBlister Tablet Packaging
DOSING INFORMATION
Beginner Use12.5 mg every other day
Intermediate Use12.5–25 mg every other day
Advanced Use25 mg/day when clinically required
AdministrationOral tablet with food
Typical Period4–12 weeks depending on purpose
ESTROGEN CONTROL
AromatasePermanent Enzyme Inhibition
Estrogen LevelReduced Conversion
OnsetSeveral Days
Peak Effect1–2 Weeks
RecoveryGradual After Discontinuation
BODYBUILDING USAGE
PurposeEstrogen Management
BulkingControls Excess Estrogen
CuttingSupports Reduced Water Retention
Cycle SupportUsed With Aromatizing Compounds
ApplicationHormonal Balance Support
USAGE PROFILE
Usage Estrogen Control During Testosterone-Based Protocols
AdministrationTablet Taken Orally
TimingSame Time Each Day
FoodPreferably With Meal
DurationShort-Term Controlled Periods
STACKING/COMPATIBILITY
Testosterone CyclesCompatible For Estrogen Management
BulkingUsed With Aromatizing Anabolics
Cutting May Support Lower Water Appearance
Support Blood Work Monitoring Recommended
Combination Avoid Excessive Estrogen Suppression
MECHANISM OF ACTION
TargetAromatase Enzyme
ActionIrreversible Inhibition
ResultReduced Estrogen Production
HormoneLower Estradiol Conversion
ClassType I Aromatase Inhibitor
PHARMACOKINETICS
AbsorptionRapid Oral Absorption
Half-LifeApproximately 24 Hours
MetabolismHepatic Metabolism
EliminationUrinary & Fecal Pathways
ActivityLong Enzyme Suppression
CONTRAINDICATIONS
PregnancyContraindicated
BreastfeedingNot Recommended
Liver DiseaseMedical Evaluation Required
Bone HealthMonitor Long-Term Use
HormonesAvoid Unnecessary Suppression
WHO IT'S FOR
Clinical UsersHormone Therapy Patients
Athletes Users Managing Estrogen Exposure
BodybuildersAdvanced Hormonal Planning
Not ForUncontrolled Self-Medication
MonitoringBlood Tests Recommended
COMPARISONS/ALTERNATIVES
ExemestaneStrong AI Control
AnastrozoleNon-Steroidal AI Alternative
LetrozoleMore Potent Estrogen Reduction
Tamoxifen SERM Estrogen Receptor Modulation
ProfilePermanent Aromatase Binding
CHEMICAL PROFILE
FormulaC20H24O2
Molecular Weight296.40 g/mol
CAS107868-30-4
ClassificationSteroidal Aromatase Inhibitor
Drug ClassEndocrine Therapy Agent
OVERVIEW
Exemestane is an oral steroidal aromatase inhibitor designed to permanently inactivate the aromatase enzyme responsible for converting androgens into estrogens. In pharmaceutical applications it is primarily used for estrogen-dependent conditions, while in bodybuilding environments it is discussed for estrogen management during anabolic steroid protocols involving aromatizing compounds.
BENEFITS
- Reduces aromatase-mediated estrogen production
- Helps manage excessive estrogen exposure
- May reduce estrogen-related water retention
- Supports hormonal balance monitoring
- Provides irreversible aromatase inhibition
- Oral administration convenience
- Long-lasting enzyme suppression profile
POTENTIAL RISKS
- Excessive estrogen suppression
- Joint discomfort and reduced lubrication
- Possible negative lipid changes
- Reduced bone mineral density with prolonged use
- Fatigue or mood changes
- Possible hormonal imbalance
- Requires monitoring during extended administration
USAGE FEATURES
Week 1–2Initial estrogen reduction phase
Week 3–6Stable aromatase suppression period
Week 6–12Continued monitoring required
Peak ActivityAfter repeated administration
Discontinuation Gradual hormonal adjustment
RECOVERY
PCT RequirementNot Typical For AI Alone
After UseMonitor Estradiol Recovery
Hormonal BalanceGradual Restoration
Monitoring TimeSeveral Weeks
SupportBlood Testing Recommended
PERFORMANCE PROFILE
Direct Anabolic Effect
10%
WHAT IS BRITISH DRAGON?
British Dragon is a pharmaceutical brand name recognized within bodybuilding communities for producing a range of performance-related pharmaceutical products. The brand has historically been associated with anabolic steroids, hormone-related products, and ancillary medications used by athletes.
Product authenticity, manufacturing standards, and regulatory status can vary depending on region and availability. Users should verify pharmaceutical information, packaging details, and applicable regulations before considering any product.
WHY CHOOSE BRITISH DRAGON?
British Dragon Exemestane 25 mg is selected by some users because of its tablet format, recognized active ingredient concentration, and the established pharmacological profile of exemestane as a steroidal aromatase inhibitor.
The primary value of exemestane is related to predictable estrogen enzyme inhibition rather than direct muscle-building activity. Its application focuses on hormonal management and maintaining controlled estrogen levels when clinically appropriate.
CONCLUSION
British Dragon Exemestane 25 mg contains exemestane, a steroidal aromatase inhibitor with a unique irreversible mechanism of estrogen enzyme suppression. Unlike anabolic compounds, exemestane does not directly increase muscle protein synthesis or strength; its role is related to estrogen regulation.
For bodybuilding-related discussions, exemestane is mainly associated with management of estrogen conversion from aromatizing anabolic steroids. Proper timing, dosage control, and hormone monitoring are essential because excessive estrogen reduction may negatively affect health, performance, and recovery.
Responsible use requires understanding individual hormone response, laboratory values, and the pharmacological characteristics of aromatase inhibition.
DISCLAIMER
This information is provided for educational and scientific purposes only. It does not represent medical advice, treatment instructions, or endorsement of non-medical pharmaceutical use. Always consider professional medical guidance and local regulations regarding pharmaceutical substances.
REFERENCES
Exemestane pharmacology and clinical information: DrugBank
Exemestane mechanism and molecular information: NCBI Review
DailyMed pharmaceutical information: DailyMed